Editorial: Updates on convalescent plasma and monoclonal antibody therapies for infectious disease in patients with primary immunodeficiency.

Condino-Neto, Antonio; Gennery, Andrew R

Condino-Neto, Antonio; Gennery, Andrew R.

Condino-Neto A; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Gennery AR; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.

Front Immunol ; 13: 1010072, 2022.

Article in English | MEDLINE | ID: covidwho-2065524

Subject(s)

Antibodies, Monoclonal; Communicable Diseases; Antibodies, Monoclonal/therapeutic use; Humans; Immunotherapy; Plasma

Keywords

antibody defects; cellular defects; combined immunodeficiencies; predominantly antibody deficiencies; treatment challenges

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases / Antibodies, Monoclonal Limits: Humans Language: English Journal: Front Immunol Year: 2022 Document Type: Article Affiliation country: Fimmu.2022.1010072

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google